Skip to main content
NCBI home page
Neuroscience Bulletin logoLink to Neuroscience Bulletin
. 2012 Feb 29;28(2):193–207. doi: 10.1007/s12264-012-1218-6

Chemokine signaling involving chemokine (C-C motif) ligand 2 plays a role in descending pain facilitation

Wei Guo 1, Hu Wang 1, Shiping Zou 1, Ronald Dubner 1, Ke Ren 1,✉
PMCID: PMC3925328  NIHMSID: NIHMS554046  PMID: 22466130

Abstract

Objective

Despite accumulating evidence on a role of immune cells and their associated chemicals in mechanisms of pain, few studies have addressed the potential role of chemokines in the descending facilitation of persistent pain. The present study was undertaken to test the hypothesis that the chemokine (C-C motif) ligand 2 (CCL2) (commonly known as monocyte chemoattractant protein-1) signaling in the rostral ventromedial medulla (RVM), a pivotal structure in brainstem pain modulatory circuitry, is involved in descending pain facilitation in rats.

Methods

An L5 spinal nerve ligation (SNL) was produced in rats under pentobarbital anesthesia. Western blot and immunohistochemistry were used to detect the expression levels of CCL2 and CCL2 receptor (CCR2), and examine their distributions compared with the neuronal marker NeuN as well as glial markers glial fibrillary acidic protein (GFAP, astroglial) and CD11b (microglial), respectively.

Results

SNL induced an increase in CCL2 expression in the RVM, and this returned to the control level at 4 weeks after injury. The induced CCL2 colocalized with NeuN, but not with GFAP and CD11b. CCR2 was also upregulated by SNL in the RVM, and this increase lasted for at least 4 weeks. CCR2 was colocalized with CD11b but not GFAP. Few RVM neurons also exhibited CCR2 staining. Neutralizing CCL2 with an anti-CCL2 antibody (0.2–20 ng) or injecting RS-102895 (0.1–10 pmol), a CCR2b chemokine receptor antagonist, into the RVM on day 1 after SNL, significantly attenuated the established thermal and mechanical hypersensitivity. In addition, injection of recombinant rat CCL2 (0.03–3 pmol) into the RVM induced dose-dependent hyperalgesia, which was prevented by pretreatment with RS-102895 (10 pmol). Interleukin-1β (IL-1β), a potent inducer of neuronal CCL2, was also selectively upregulated in RVM reactive astrocytes. Injection of IL-1β (120 fmol) into the RVM induced behavioral hyperalgesia, which was blocked by RS-102895 (10 pmol). However, an IL-1 receptor antagonist (3 pmol) did not prevent CCL2 (3 pmol)-induced hyperalgesia. These results suggest that the effect of CCL2 is downstream to IL-1β signaling.

Conclusion

The IL-1β and CCL2-CCR2 signaling cascades play a role in neuron-glia-cytokine interactions and the descending facilitation of neuropathic pain.

Keywords: monocyte chemoattractant protein-1, chemokine (C-C motif) receptor 2, rostral ventromedial medulla, neuron-glial interaction, neuropathic pain, rat

Footnotes

These authors contributed equally to this work.

References

  • [1].Bonica J.J. Pain research and therapy: Past and current status and future needs. In: Ng L.K.Y., Bonica J.J., editors. Pain, Discomfort and Humanitarian Care. Volume 4. New York: Elsevier/North-Holland; 1980. pp. 1–47. [Google Scholar]
  • [2].Porreca F., Ossipov M.H., Gebhart G.F. Chronic pain and medullary descending facilitation. Trends Neurosci. 2002;25:319–325. doi: 10.1016/S0166-2236(02)02157-4. [DOI] [PubMed] [Google Scholar]
  • [3].Ren K., Dubner R. Descending modulation in persistent pain: an update. Pain. 2002;100:1–6. doi: 10.1016/S0304-3959(02)00368-8. [DOI] [PubMed] [Google Scholar]
  • [4].Wiertelak E.P., Roemer B., Maier S.F., Watkins L.R. Comparison of the effects of nucleus tractus solitarius and ventral medial medulla lesions on illness-induced and subcutaneous formalin-induced hyperalgesias. Brain Res. 1997;748:143–150. doi: 10.1016/S0006-8993(96)01289-9. [DOI] [PubMed] [Google Scholar]
  • [5].Ren K., Dubner R. Descending control mechanisms. In: Bushnell M.C., Basbaum A.I., editors. The Senses: A Comprehensive Reference. Volume 5: Pain. San Diego: Academic Press; 2008. pp. 723–762. [Google Scholar]
  • [6].Wei F., Guo W., Zou S., Ren K., Dubner R. Supraspinal glialneuronal interactions contribute to descending pain facilitation. J Neurosci. 2008;28:10482–10495. doi: 10.1523/JNEUROSCI.3593-08.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [7].Watkins L.R., Maier S.F. Immune regulation of central nervous system functions: from sickness responses to pathological pain. J Intern Med. 2005;257:139–155. doi: 10.1111/j.1365-2796.2004.01443.x. [DOI] [PubMed] [Google Scholar]
  • [8].Scholz J., Woolf C.J. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci. 2007;10:1361–1368. doi: 10.1038/nn1992. [DOI] [PubMed] [Google Scholar]
  • [9].Gao Y.J., Ji R.R. Chemokines, neuronal-glial interactions, and central processing of neuropathic pain. Pharmacol Ther. 2010;126:56–68. doi: 10.1016/j.pharmthera.2010.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [10].Ren K., Dubner R. Neuron-glia crosstalk gets serious: role in pain hypersensitivity. Curr Opin Anaesthesiol. 2008;21:570–579. doi: 10.1097/ACO.0b013e32830edbdf. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [11].Ren K., Dubner R. Interactions between the immune and nervous systems in pain. Nat Med. 2010;16:1267–1276. doi: 10.1038/nm.2234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [12].White F.A., Miller R.J. Insights into the regulation of chemokine receptors by molecular signaling pathways: functional roles in neuropathic pain. Brain Behav Immun. 2010;24:859–865. doi: 10.1016/j.bbi.2010.03.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [13].Old E.A., Malcangio M. Chemokine mediated neuron-glia communication and aberrant signalling in neuropathic pain states. Curr Opin Pharmacol. 2011;12:1–7. doi: 10.1016/j.coph.2011.10.015. [DOI] [PubMed] [Google Scholar]
  • [14].Zhang J., De Koninck Y. Spatial and temporal relationship between monocyte chemoattractant protein-1 expression and spinal glial activation following peripheral nerve injury. J Neurochem. 2006;97:772–783. doi: 10.1111/j.1471-4159.2006.03746.x. [DOI] [PubMed] [Google Scholar]
  • [15].Bhangoo S., Ren D., Miller R.J., Henry K.J., Lineswala J., Hamdouchi C., et al. Delayed functional expression of neuronal chemokine receptors following focal nerve demyelination in the rat: a mechanism for the development of chronic sensitization of peripheral nociceptors. Mol Pain. 2007;3:38. doi: 10.1186/1744-8069-3-38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [16].Jung H., Toth P.T., White F.A., Miller R.J. Monocyte chemoattractant protein-1 functions as a neuromodulator in dorsal root ganglia neurons. J Neurochem. 2008;104:254–263. doi: 10.1111/j.1471-4159.2007.04969.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [17].Van Steenwinckel J., Reaux-Le Goazigo A., Pommier B., Mauborgne A., Dansereau M.A., Kitabgi P., et al. CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury. J Neurosci. 2011;31:5865–5875. doi: 10.1523/JNEUROSCI.5986-10.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [18].White F.A., Sun J., Waters S.M., Ma C., Ren D., Ripsch M., et al. Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion. Proc Natl Acad Sci U S A. 2005;102:14092–14097. doi: 10.1073/pnas.0503496102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [19].Tsakiri N., Kimber I., Rothwell N.J., Pinteaux E. Differential effects of interleukin-1 alpha and beta on interleukin-6 and chemokine synthesis in neurones. Mol Cell Neurosci. 2008;38:259–265. doi: 10.1016/j.mcn.2008.02.015. [DOI] [PubMed] [Google Scholar]
  • [20].Abbadie C., Lindia J.A., Cumiskey A.M., Peterson L.B., Mudgett J.S., Bayne E.K., et al. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc Natl Acad Sci U S A. 2003;100:7947–7952. doi: 10.1073/pnas.1331358100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [21].Zhang J., Shi X.Q., Echeverry S., Mogil J.S., De Koninck Y., Rivest S. Expression of CCR2 in both resident and bone marrow-derived microglia plays a critical role in neuropathic pain. J Neurosci. 2007;27:12396–12406. doi: 10.1523/JNEUROSCI.3016-07.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [22].Knerlich-Lukoschus F., Juraschek M., Blömer U., Lucius R., Mehdorn H.M., Held-Feindt J. Force-dependent development of neuropathic central pain and time-related CCL2/CCR2 expression after graded spinal cord contusion injuries of the rat. J Neurotrauma. 2008;25:427–448. doi: 10.1089/neu.2007.0431. [DOI] [PubMed] [Google Scholar]
  • [23].Gao Y.J., Zhang L., Samad O.A., Suter M.R., Yasuhiko K., Xu Z.Z., et al. JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. J Neurosci. 2009;1:4096–4108. doi: 10.1523/JNEUROSCI.3623-08.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [24].Sun J.H., Yang B., Donnelly D.F., Ma C., LaMotte R.H. MCP-1 enhances excitability of nociceptive neurons in chronically compressed dorsal root ganglia. J Neurophysiol. 2006;96:2189–2199. doi: 10.1152/jn.00222.2006. [DOI] [PubMed] [Google Scholar]
  • [25].Belkouch M., Dansereau M.A., Réaux-Le Goazigo A., Van Steenwinckel J., Beaudet N., Chraibi A., et al. The Chemokine CCL2 increases Nav1.8 sodium channel activity in primary sensory neurons through a GβΓ-dependent mechanism. J Neurosci. 2011;31:18381–18390. doi: 10.1523/JNEUROSCI.3386-11.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [26].Serrano A., Paré M., McIntosh F., Elmes S.J., Martino G., Jomphe C., et al. Blocking spinal CCR2 with AZ889 reversed hyperalgesia in a model of neuropathic pain. Mol Pain. 2010;6:90. doi: 10.1186/1744-8069-6-90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [27].Bogen O., Dina O.A., Gear R.W., Levine J.D. Dependence of monocyte chemoattractant protein 1 induced hyperalgesia on the isolectin B4-binding protein versican. Neuroscience. 2009;159:780–786. doi: 10.1016/j.neuroscience.2008.12.049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [28].Thacker M.A., Clark A.K., Bishop T., Grist J., Yip P.K., Moon L.D., et al. CCL2 is a key mediator of microglia activation in neuropathic pain states. Eur J Pain. 2009;13:263–272. doi: 10.1016/j.ejpain.2008.04.017. [DOI] [PubMed] [Google Scholar]
  • [29].Menetski J., Mistry S., Lu M., Mudgett J.S., Ransohoff R.M., Demartino J.A., et al. Mice overexpressing chemokine ligand 2 (CCL2) in astrocytes display enhanced nociceptive responses. Neuroscience. 2007;149:706–714. doi: 10.1016/j.neuroscience.2007.08.014. [DOI] [PubMed] [Google Scholar]
  • [30].Padi SS, Shi XQ, Zhao YQ, Ruff MR, Baichoo N, Pert CB, et al. Attenuation of rodent neuropathic pain by an orally active peptide, RAP-103, which potently blocks CCR2- and CCR5-mediated monocyte chemotaxis and inflammation. Pain 2011. [Epub ahead of print] [DOI] [PubMed]
  • [31].Szabo I., Chen X.H., Xin L., Adler M.W., Howard O.M., Oppenheim J.J., et al. Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain. Proc Natl Acad Sci U S A. 2002;99:10276–10281. doi: 10.1073/pnas.102327699. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [32].Kim S.H., Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 1992;50:355–363. doi: 10.1016/0304-3959(92)90041-9. [DOI] [PubMed] [Google Scholar]
  • [33].Paxinos P., Watson C. The Rat Brain in Stereotaxic Coordinates. 6th ed. New York: Academic Press; 2008. [Google Scholar]
  • [34].Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 1988;32:77–88. doi: 10.1016/0304-3959(88)90026-7. [DOI] [PubMed] [Google Scholar]
  • [35].Ren K. An improved method for assessing mechanical allodynia in the rat. Physiol Beh. 1999;67:711–716. doi: 10.1016/S0031-9384(99)00136-5. [DOI] [PubMed] [Google Scholar]
  • [36].Guo W., Wei F., Zou S., Robbins M.T., Sugiyo S., Ikeda T., et al. Group I metabotropic glutamate receptor NMDA receptor coupling and signaling cascade mediate spinal dorsal horn NMDA receptor 2B tyrosine phosphorylation associated with inflammatory hyperalgesia. J Neurosci. 2004;24:9161–9173. doi: 10.1523/JNEUROSCI.3422-04.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [37].Graves D.T., Jiang Y. Chemokines, a family of chemotactic cytokines. Crit Rev Oral Biol Med. 1995;6:109–118. doi: 10.1177/10454411950060020101. [DOI] [PubMed] [Google Scholar]
  • [38].Tran P.B., Miller R.J. Chemokine receptors: signposts to brain devel opment and disease. Nat Rev Neurosci. 2003;4:444–455. doi: 10.1038/nrn1116. [DOI] [PubMed] [Google Scholar]
  • [39].Thibeault I., Laflamme N., Rivest S. Regulation of the gene encoding the monocyte chemoattractant protein 1 (MCP-1) in the mouse and rat brain in response to circulating LPS and proinflammatory cytokines. J Comp Neurol. 2001;434:461–477. doi: 10.1002/cne.1187. [DOI] [PubMed] [Google Scholar]
  • [40].Banisadr G., Gosselin R.D., Mechighel P., Kitabgi P., Rostène W., Parsadaniantz S.M. Highly regionalized neuronal expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) in rat brain: evidence for its colocalization with neurotransmitters and neuropeptides. J Comp Neurol. 2005;489:275–292. doi: 10.1002/cne.20598. [DOI] [PubMed] [Google Scholar]
  • [41].Gao Y.J., Zhang L., Ji R.R. Spinal injection of TNF-α-activated astrocytes produces persistent pain symptom mechanical allodynia by releasing monocyte chemoattractant protein-1. Glia. 2010;58:1871–1880. doi: 10.1002/glia.21056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [42].Tanaka T., Minami M., Nakagawa T., Satoh M. Enhanced production of monocyte chemoattractant protein-1 in the dorsal root ganglia in a rat model of neuropathic pain: possible involvement in the development of neuropathic pain. Neurosci Res. 2004;48:463–469. doi: 10.1016/j.neures.2004.01.004. [DOI] [PubMed] [Google Scholar]
  • [43].van der Meer P., Ulrich A.M., Gonźalez-Scarano F., Lavi E. Immunohistochemical analysis of CCR2, CCR3, CCR5, and CXCR4 in the human brain: potential mechanisms for HIV dementia. Exp Mol Pathol. 2000;69:192–201. doi: 10.1006/exmp.2000.2336. [DOI] [PubMed] [Google Scholar]
  • [44].Banisadr G., Quéraud-Lesaux F., Boutterin M.C., Pélaprat D., Zalc B., Rostène W., et al. Distribution, cellular localization and functional role of CCR2 chemokine receptors in adult rat brain. J Neurochem. 2002;81:257–269. doi: 10.1046/j.1471-4159.2002.00809.x. [DOI] [PubMed] [Google Scholar]
  • [45].Gosselin R.D., Varela C., Banisadr G., Mechighel P., Rostene W., Kitabgi P., et al. Constitutive expression of CCR2 chemokine receptor and inhibition by MCP-1/CCL2 of GABA-induced currents in spinal cord neurones. J Neurochem. 2005;95:1023–1034. doi: 10.1111/j.1471-4159.2005.03431.x. [DOI] [PubMed] [Google Scholar]
  • [46].Jung H., Bhangoo S., Banisadr G., Freitag C., Ren D., White F.A., et al. Visualization of chemokine receptor activation in transgenic mice reveals peripheral activation of CCR2 receptors in states of neuropathic pain. J Neurosci. 2009;29:8051–8062. doi: 10.1523/JNEUROSCI.0485-09.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [47].De Leo J.A., Tawfik V.L., LaCroix-Fralish M.L. The tetrapartite synapse: path to CNS sensitization and chronic pain. Pain. 2006;122:17–21. doi: 10.1016/j.pain.2006.02.034. [DOI] [PubMed] [Google Scholar]
  • [48].Ren K., Wei F. Neuron-glial interaction in descending modulation of persistent pain. In: Schmidt R.F., Gebhart G.F., editors. Encyclopedic Reference of Pain. Volume 3. 2nd ed. Heidelberg New York: Springer-Verlag; 2011. [Google Scholar]
  • [49].Roberts J., Ossipov M.H., Porreca F. Glial activation in the rostroventromedial medulla promotes descending facilitation to mediate inflammatory hypersensitivity. Eur J Neurosci. 2009;30:229–241. doi: 10.1111/j.1460-9568.2009.06813.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [50].El Khoury J., Toft M., Hickman S.E., Means T.K., Terada K., Geula C., et al. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med. 2007;13:432–438. doi: 10.1038/nm1555. [DOI] [PubMed] [Google Scholar]
  • [51].Guo W., Wang H., Watanabe M., Shimizu K., Zou S., LaGraize S.C., et al. Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J Neurosci. 2007;27:6006–6018. doi: 10.1523/JNEUROSCI.0176-07.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [52].Gu M., Miyoshi K., Dubner R., Guo W., Zou S., Ren K., et al. Spinal 5-HT(3) receptor activation induces behavioral hypersensitivity via a neuronal-glial-neuronal signaling cascade. J Neurosci. 2011;31:12823–12836. doi: 10.1523/JNEUROSCI.1564-11.2011. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
  • [53].Baamonde A., Hidalgo A., Menéndez L. Involvement of glutamate NMDA and AMPA receptors, glial cells and IL-1β in the spinal hyperalgesia evoked by the chemokine CCL2 in mice. Neurosci Lett. 2011;502:178–181. doi: 10.1016/j.neulet.2011.07.038. [DOI] [PubMed] [Google Scholar]
  • [54].Flügel A., Hager G., Horvat A., Spitzer C., Singer G.M., Graeber M.B., et al. Neuronal MCP-1 expression in response to remote nerve injury. J Cereb Blood Flow Metab. 2001;21:69–76. doi: 10.1097/00004647-200101000-00009. [DOI] [PubMed] [Google Scholar]
  • [55].Wei F., Dubner R., Zou S., Ren K., Bai G., Wei D., et al. Molecular depletion of descending serotonin unmasks its novel facilitatory role in the development of persistent pain. J Neurosci. 2010;30:8624–8636. doi: 10.1523/JNEUROSCI.5389-09.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Neuroscience Bulletin are provided here courtesy of Springer

RESOURCES